Successful transcatheter treatment of severe cardiac failure, a world first

September 11, 2017

The Cardiovascular Surgery Group at Osaka University performed a transcatheter mitral valve implantation in dysfunctional artificial valves in severe cardiac failure patients with prosthetic valve dysfunction, which was previously thought to be incurable or high-risk, succeeding in improving the cardiac function of these patients. In the future, this technique is anticipated as a new therapy for the treatment of prosthetic valve dysfunction in patients with serious heart failure who are either inoperable or require a post-surgery auxiliary artificial heart.

Led by Professor Yoshiki SAWA, the Cardiovascular Group in the Graduate School of Medicine, Osaka University, has developed a wide variety of treatment for severe heart failure, such as skeletal myoblast cell sheet transplantation. This group has performed over 500 transcatheter valve replacement surgeries, a technique that is gathering attention as minimally invasive heart surgery, establishing Osaka University Hospital's role as one of Japan's leading medical institutes.

Cardiac surgery in patients with severe heart failure has been thought to entail a significant risk due to surgical stress. The risk of reoperation is especially high when a prosthetic valve becomes dysfunctional. Also, surgical stress may further deteriorate cardiac function in patients waiting for heart transplants, increasing their need for an auxiliary artificial heart.

This time, Prof. Sawa's group succeeded in transcatheter mitral valve implantation in patients with severe heart failure in clinical research for transcatheter aortic valve implantation (TAVI), a new therapeutic method which the group had actively performed. Because this therapeutic method has enabled minimally invasive treatment on patients who were previously regarded as being incurable or high-risk, it is highly anticipated as a new treatment method for prosthetic valve dysfunction in patients with severe heart failure.
-end-


Osaka University

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.